Summary Background Data. Transhepatic intubation by a variety of methods has been used routinely for biliary decompression and inhibition of anastomotic stricture since the 1960s. U tubes were popularized in the early 1970s. However, little has been written about their use and efficacy in recent years. Because of the apparent benefits associated with the use of U tubes versus other stenting techniques, the authors performed this study. Methods. The hospital and office charts ofaH patients who had U tubes placed between 1980 and 1992 were reviewed retrospectively. Between 1980 and 1992, U tubes were placed intraoperatively in 54 patients for biliary decompression and/or stenting. Twelve patients were operated on for benign causes of obstruction. Forty-two patients with malignant tumors underwent surgery for U tube placement in conjunction with or without tumor resection and anastomotic bypass.
Results. There was a 0% operative mortality rate in the benign group. In six patients, the U tube played a major role in the long-term management of their disease processes. None of these patients has had restricture since removal of the tube. In the malignant group, the 30-day operative mortality rate was 12%. After 3 months, marked clinical improvement and complete biliary decompression were achieved, with mean bilirubin levels dropping from 14.0 mg/dL to The controversy over the best type of operativelyplaced transhepatic stent remains unsettled by this report ,2. Supporters ofU tubes (which exit the skin at two sites) favor their use because of the stated ease of exchange and high levels of patient acceptance with the cleaning procedure. Supporters of straight transhepatic tubes (which exit the skin at only one site, with the internal aspect of the stent typically residing in a Roux-en-Y loop of bowel used for biliary-enteric anastomosis) favor their use because the number of exit sites per patient is reduced and the tube exchange process has become a simple outpatient procedure. Prospective data comparing U tubes and straight tubes are lacking, and thus the resolution of this controversy remains largely emotional and based upon the surgeon's preference. We favor straight transhepatic tubes, which are often inserted using pre-existing percutaneously-placed transhepatic "Ring" catheters, or can be inserted transhepatically at the time of laparotomy3. Several issues addressed by the article of Millikan et al. deserve further mention: the challenging pattern of iatrogenic bile duct injuries, the emergence of non-surgical options for bile duct obstruction, and the need for a multidisciplinary approach to many patients with obstructivejaundice.
First, in their group of 12 patients with benign bile duct strictures only one stricture involved the common hepatic duct and only one stricture was above the hepatic duct bifurcation. The recent introduction, popularization and widespread use oflaparoscopic cholecystectomy has been associated with an increased incidence of bile duct injuries, many ofwhich involve the common hepatic duct or its bifurcation4-6. Repair of such bile duct injuries has been reported both early and late after their occurrence, and not uncommonly has required bilateral hepaticojejunostomy, with transhepatic stents used to traverse both the right and left lobes of the liver.
Second, Millikan et al. treated 42 patients with malignant biliary obstruction with U tube stenting, with 18 patients undergoing tumor resection (9 "curative", 9 palliative) and 24 patients undergoing U tube placement for palliation, without tumor resection. In this entire group ofpatients the 30 day postoperative mortality rate was 12% and in-hospital mortality rate was 26%, rates that are similar to some series 78 but not much higher than other reported concurrent series 8 In conclusion, the management of patients with obstructive jaundice from either benign or malignant processes no longer resides solely within the hands of surgeons. A multidisciplinary approach to such a problems is currently indicated, with some patients being best treated by endoscopic or percutaneous techniques, others by surgical techniques, and still others using a multidisciplinary approach. Operatively placed transhepatic stents continue to play an important role in the management of these patients. So do the procedures performed by our talented endoscopists and interventional radiologists.
